Quarterly Results

  • Company Name :
Neuland Laboratories Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524558
  • NSE Symbol:
  • NEULANDLAB
  • P/E(TTM):
  • 94.58
  • ISIN Demat:
  • INE794A01010
  • Div & Yield%:
  • 0.08
  • EPS(TTM):
  • 161.75
  • Book Value(₹):
  • 1,182.30
  • Market Cap(₹Cr.):
  • 19,628.32
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 328.36 398.03 310.84
Excise Duty 0.00 0.00 0.00
Net Sales 328.36 398.03 310.84
Other Operating Income 0.00 0.00 0.00
Other Income 7.46 59.68 4.33
Total Income 335.82 457.72 315.18
Total Expenditure 277.61 311.66 249.50
PBIDT 58.22 146.06 65.67
Interest 2.35 2.22 1.06
PBDT 55.87 143.84 64.61
Depreciation 16.89 16.30 16.07
Tax 5.94 24.92 12.21
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 5.31 1.23 4.37
Reported Profit After Tax 27.73 101.39 31.96
Extra-ordinary Items 0.00 44.34 0.00
Adjusted Profit After Extra-ordinary item 27.73 57.05 31.96
EPS (Unit Curr.) 21.62 79.03 24.91
EPS (Adj) (Unit Curr.) 21.62 79.03 24.91
Calculated EPS (Unit Curr.) 21.50 78.60 24.77
Calculated EPS (Adj) (Unit Curr.) 21.50 78.60 24.77
Calculated EPS (Ann.) (Unit Curr.) 85.99 314.39 99.09
Calculated EPS (Adj) (Ann.) (Unit Curr.) 85.99 314.39 99.09
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 12.90 12.90 12.90
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 17.73 36.70 21.13
PBDTM(%) 17.01 36.14 20.79
PATM(%) 8.44 25.47 10.28